Your browser doesn't support javascript.
loading
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2.
Szubert, Alex J; Pollock, Katrina M; Cheeseman, Hannah M; Alagaratnam, Jasmini; Bern, Henry; Bird, Olivia; Boffito, Marta; Byrne, Ruth; Cole, Tom; Cosgrove, Catherine A; Faust, Saul N; Fidler, Sarah; Galiza, Eva; Hassanin, Hana; Kalyan, Mohini; Libri, Vincenzo; McFarlane, Leon R; Milinkovic, Ana; O'Hara, Jessica; Owen, David R; Owens, Daniel; Pacurar, Mihaela; Rampling, Tommy; Skene, Simon; Winston, Alan; Woolley, James; Yim, Yee Ting N; Dunn, David T; McCormack, Sheena; Shattock, Robin J.
Afiliação
  • Szubert AJ; cMRC Clinical Trials Unit at UCL, London, UK.
  • Pollock KM; Department of Infectious Disease, Imperial College London, UK.
  • Cheeseman HM; NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK.
  • Alagaratnam J; Department of Infectious Disease, Imperial College London, UK.
  • Bern H; Department of Infectious Disease, Imperial College London, UK.
  • Bird O; cMRC Clinical Trials Unit at UCL, London, UK.
  • Boffito M; St George's Vaccine Institute, Institute for Infection and Immunity, St George's University of London, UK.
  • Byrne R; Chelsea & Westminster Hospital, London, UK.
  • Cole T; Chelsea & Westminster Hospital, London, UK.
  • Cosgrove CA; NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK.
  • Faust SN; St George's Vaccine Institute, Institute for Infection and Immunity, St George's University of London, UK.
  • Fidler S; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Galiza E; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
  • Hassanin H; Department of Infectious Disease, Imperial College London, UK.
  • Kalyan M; St George's Vaccine Institute, Institute for Infection and Immunity, St George's University of London, UK.
  • Libri V; Surrey Clinical Research Facility, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
  • McFarlane LR; Department of Infectious Disease, Imperial College London, UK.
  • Milinkovic A; dNIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, London, UK.
  • O'Hara J; Department of Infectious Disease, Imperial College London, UK.
  • Owen DR; Chelsea & Westminster Hospital, London, UK.
  • Owens D; Department of Infectious Disease, Imperial College London, UK.
  • Pacurar M; NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK.
  • Rampling T; Department of Brain Sciences, Imperial College London, London, UK.
  • Skene S; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Winston A; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
  • Woolley J; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Yim YTN; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
  • Dunn DT; dNIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, London, UK.
  • McCormack S; Surrey Clinical Research Facility, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
  • Shattock RJ; Department of Infectious Disease, Imperial College London, UK.
EClinicalMedicine ; 56: 101823, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36684396

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article